Method for inhibiting ebola virus via mirna
AssigneeJiangsu Micromedmark Biotech Co., Ltd.
InventorsChenyu ZHANG, Hongwei LIANG, Zhen ZHOU, Ke ZENG, Xi CHEN
Life of this patent
Estimating the term…
Abstract
Provided are a method and use of microRNA MiR-2911 in regulating an ebola virus. Particularly provided are a method and use of isolated microRNA MiR-2911 in regulating an ebola virus protein gene.
Claims12
1-10. (canceled)
A method for preventing or treating Ebola virus diseases, wherein the method comprises the following step:
- administering MIR-2911 or an extract or a composition containing MIR-2911 to a subject in need thereof.
A method for inhibiting destruction or death of endothelial cells caused by GP of Ebola virus, wherein the method comprises the following step:
- administering MIR2911 or an extract or a composition containing MIR2911 to a subject in need thereof.
A method for inhibiting Ebola virus, wherein the method comprises the step of contacting miR2911 with Ebola virus or cells infected with Ebola virus.
A composition for use in inhibiting replication of Ebola virus and/or treating Ebola virus infection, wherein the composition contains (a) a carrier acceptable in pharmaceutics or bromatology;
- and (b) an active ingredient, the active ingredient comprises miR2911.
Dependencies are inferred from the claim text.